Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joanna Laurson-Doube

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Clinical Epidemiology|March 27, 2025
GRADE notes 5: comparing a new intervention with an established treatment. Practical and methodological issuesFrancesco Nonino, Elisa Baldin, Nick Rijke, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 13, 2021
Multiple Sclerosis International Federation guideline methodology for off-label treatments for multiple sclerosisThomas Piggott, Francesco Nonino, Elisa Baldin, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 17, 2020
World Health Organization Essential Medicines List: Multiple sclerosis disease-modifying therapies applicationJennifer McDonell, Kathleen Costello, Joanna Laurson-Doube, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 26, 2021
Ethical use of off-label disease-modifying therapies for multiple sclerosisJoanna Laurson-Doube, Nick Rijke, Anne Helme, et al.
Neurology|June 15, 2023
Global Barriers to the Diagnosis of Multiple Sclerosis: Data From the Multiple Sclerosis International Federation Atlas of MS, Third EditionAndrew J Solomon, Ruth Ann Marrie, Shanthi Viswanathan, et al.
Journal of Clinical Epidemiology|December 20, 2023
GRADE Concept 7: Issues and Insights Linking Guideline Recommendations to Trustworthy Essential Medicine ListsThomas Piggott, Lorenzo Moja, Kristina Jenei, et al.
Multiple Sclerosis and Related Disorders|March 4, 2022
Identifying unanswered questions and setting the agenda for future systematic research in Multiple Sclerosis. A worldwide, multi-stakeholder Priority Setting projectMaria Grazia Celani, Francesco Nonino, Kathryn Mahan, et al.
Multiple Sclerosis and Related Disorders|March 28, 2024
Multi-actor system dynamics in access to disease-modifying treatments for multiple sclerosis in Southeast Asia: A regional survey and suggestions for improvementShanthi Viswanathan, Lavanya Vijayasingham, Joanna Laurson-Doube, et al.
Multiple Sclerosis and Related Disorders|December 2, 2025
Recommendations for the use of off-label rituximab for the treatment of multiple sclerosis in low-resource settingsNick Rijke, Bassem I Yamout, Deanna Saylor, et al.
The Lancet. Global Health|March 14, 2024
National plans and awareness campaigns as priorities for achieving global brain healthSebastian F Winter, Donna Walsh, Coriene Catsman-Berrevoets, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Clinical Epidemiology|March 27, 2025
GRADE notes 5: comparing a new intervention with an established treatment. Practical and methodological issuesFrancesco Nonino, Elisa Baldin, Nick Rijke, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 13, 2021
Multiple Sclerosis International Federation guideline methodology for off-label treatments for multiple sclerosisThomas Piggott, Francesco Nonino, Elisa Baldin, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 17, 2020
World Health Organization Essential Medicines List: Multiple sclerosis disease-modifying therapies applicationJennifer McDonell, Kathleen Costello, Joanna Laurson-Doube, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 26, 2021
Ethical use of off-label disease-modifying therapies for multiple sclerosisJoanna Laurson-Doube, Nick Rijke, Anne Helme, et al.
Neurology|June 15, 2023
Global Barriers to the Diagnosis of Multiple Sclerosis: Data From the Multiple Sclerosis International Federation Atlas of MS, Third EditionAndrew J Solomon, Ruth Ann Marrie, Shanthi Viswanathan, et al.
Journal of Clinical Epidemiology|December 20, 2023
GRADE Concept 7: Issues and Insights Linking Guideline Recommendations to Trustworthy Essential Medicine ListsThomas Piggott, Lorenzo Moja, Kristina Jenei, et al.
Multiple Sclerosis and Related Disorders|March 4, 2022
Identifying unanswered questions and setting the agenda for future systematic research in Multiple Sclerosis. A worldwide, multi-stakeholder Priority Setting projectMaria Grazia Celani, Francesco Nonino, Kathryn Mahan, et al.
Multiple Sclerosis and Related Disorders|March 28, 2024
Multi-actor system dynamics in access to disease-modifying treatments for multiple sclerosis in Southeast Asia: A regional survey and suggestions for improvementShanthi Viswanathan, Lavanya Vijayasingham, Joanna Laurson-Doube, et al.
Multiple Sclerosis and Related Disorders|December 2, 2025
Recommendations for the use of off-label rituximab for the treatment of multiple sclerosis in low-resource settingsNick Rijke, Bassem I Yamout, Deanna Saylor, et al.
The Lancet. Global Health|March 14, 2024
National plans and awareness campaigns as priorities for achieving global brain healthSebastian F Winter, Donna Walsh, Coriene Catsman-Berrevoets, et al.
Pageof 2